A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)

- Wigg, Alan, Tibballs, Jonathan, Haworth, Annette, Hardcastle, Nicholas, Loo, Kee Fong, Tang, Colin, Lee, Yoo Young, Chu, Julie, De Abreu Lourenco, Richard, Koukourou, Adam, De Boo, Diederick, McLean, Kate, Woodman, Richard, Buck, Jackie, Sawhney, R, Nicoll, A, Dev, A, Wood, M, Braund, A, Weltman, M, Khor, R, Levy, M, Wang, T, Stuart, Katherine, Potter, M, Haridy, J, Raj, A, Duncan, O, Zekry, A, Collier, N, O’Beirne, J, Holliday, C, Trada, Y, Tronidjaja, J, Le, Hien, George, J, Pryor, D, Roberts, Stuart K., Olynyk, John K., Strasser, Simone I., Wallace, Michael, Martin, Jarad

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial

- Siva, Shankar, Bressel, Mathias, Lin, Charles, Raman, Avi, Hardcastle, Nicholas, Hofman, Michael S., De Abreu Lourenco, Richard, Shaw, Mark, Mancuso, Pascal, Moon, Daniel, Wong, Lih-Ming, Lawrentschuk, Nathan, Sidhom, Mark, Wood, S, Brook, NR, Kron, T, Martin, Jarad, Pryor, D, FASTRACK II Investigator Group,, Sridharan, Swetha, Vanneste, Ben G. L., Davey, Ryan, Montgomery, Rebecca, Ruben, Jeremy, Foroudi, Farshad, Higgs, Braden

Credentialing of vertebral stereotactic ablative body radiotherapy in a multi-centre trial

- Hardcastle, Nicholas, Kron, Tomas, Cook, Olivia, Lehmann, Joerg, Mitchell, Paul L. R., Siva, Shankar

Geometric uncertainty analysis of MLC tracking for lung SABR

- Caillet, Vincent, Zwan, Benjamin, Briggs, Adam, Hardcastle, Nicholas, Szymura, Kathryn, Prodreka, Alexander, O'Brien, Ricky, Harris, Ben E., Greer, Peter, Haddad, Carol, Jayamanne, Dasantha, Eade, Thomas, Booth, Jeremy, Keall, Paul